(Q41454750)

30 September 2017

1 reference

title

A pivotal role for glutamate in the pathogenesis of schizophrenia, and its cognitive dysfunction (English)

1 reference

30 September 2017

0 references

Hirsch SR

1

1 reference

30 September 2017

Das I

series ordinal

2

1 reference

30 September 2017

Garey LJ

series ordinal

3

1 reference

30 September 2017

de Belleroche J

series ordinal

4

1 reference

30 September 2017

language of work or name

English

0 references

publication date

1 April 1997

1 reference

Pharmacology, Biochemistry and Behavior

30 September 2017

published in

1 reference

30 September 2017

volume

56

1 reference

30 September 2017

issue

4

1 reference

30 September 2017

page(s)

797-802

1 reference

Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients

30 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900428-5

7 January 2021

Phencyclidine-induced psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900428-5

7 January 2021

A synaptic model of memory: long-term potentiation in the hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900428-5

7 January 2021

A randomised controlled trial of prophylactic neuroleptic treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900428-5

7 January 2021

Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900428-5

7 January 2021

Decreased expression of mRNAs encoding non-NMDA glutamate receptors GluR1 and GluR2 in medial temporal lobe neurons in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900428-5

7 January 2021

Role of glutamate and glutamate receptors in memory function and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900428-5

7 January 2021

Regional brain activity in chronic schizophrenic patients during the performance of a verbal fluency task.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900428-5

7 January 2021

Activation of NMDA receptors induces dephosphorylation of DARPP-32 in rat striatal slices

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900428-5

7 January 2021

The effects of some polyamines on putative behavioural indices of mesolimbic versus striatal dopaminergic function

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900428-5

7 January 2021

Impaired mismatch negativity generation reflects widespread dysfunction of working memory in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900428-5

7 January 2021

The role of excitatory amino acids in neuropsychiatric illness

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900428-5

7 January 2021

Recent advances in the phencyclidine model of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900428-5

7 January 2021

Amelioration of negative symptoms in schizophrenia by glycine.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900428-5

7 January 2021

Asymmetrical loss of glutamate receptor subtype in left hippocampus in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900428-5

7 January 2021

Quantitative autoradiographic analysis of glutamate binding sites in the hippocampal formation in normal and schizophrenic brain post mortem

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900428-5

7 January 2021

Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900428-5

7 January 2021

The origin of efferent pathways from the primary visual cortex, area 17, of the macaque monkey as shown by retrograde transport of horseradish peroxidase

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900428-5

7 January 2021

Glutamate: its role in learning, memory, and the aging brain

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900428-5

7 January 2021

Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900428-5

7 January 2021

Increased [3H]kainic acid binding in the prefrontal cortex in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900428-5

7 January 2021

Glutamate receptor dysfunction and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900428-5

7 January 2021

Stimulatory effect of L-glutamate and related amino acids on [3H]dopamine release from rat striatum: an in vitro model for glutamate actions

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900428-5

7 January 2021

Dopamine receptors localised on cerebral cortical afferents to rat corpus striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900428-5

7 January 2021

Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900428-5

7 January 2021

Regional changes in [3H]D-aspartate and [3H]TCP binding sites in Alzheimer's disease brains

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900428-5

7 January 2021

Alterations in phencyclidine and sigma binding sites in schizophrenic brains. Effects of disease process and neuroleptic medication.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900428-5

7 January 2021

Light and electron microscopic characterization of dopamine-immunoreactive axons in human cerebral cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900428-5

7 January 2021

The behavioral and neurochemical effects of phencyclidine in humans and animals: some implications for modeling psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900428-5

7 January 2021

Neurotransmitters, receptors and neuropeptides in post-mortem brains of chronic schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900428-5

7 January 2021

Excitatory amino acid receptors in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900428-5

7 January 2021

Glycine therapy of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900428-5

7 January 2021

10.1016/S0091-3057(96)00428-5

Identifiers

DOI

1 reference

release_ehswhd2bsfczlcetm4bfbxnjxu

30 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ehswhd2bsfczlcetm4bfbxnjxu

24 November 2022

mapped directly with Wikidata item

1 reference